Why is a patient with gonorrhea receiving both ceftriaxone and doxycycline?

Why is a patient with gonorrhea receiving both ceftriaxone and doxycycline?

• A. To eradicate the infection faster than a single antibiotic.
• B. Because many gonorrhea cases co-occur with chlamydia.
• C. To reduce the risk of reinfection.
• D. To address possible resistant strains of gonorrhea.

Answer: (B)

The patient with gonorrhea is receiving both ceftriaxone and doxycycline primarily because many cases of gonorrhea are co-infected with chlamydia. Chlamydia is another sexually transmitted infection that is often asymptomatic but can have serious complications if left untreated. By administering both antibiotics, the treatment addresses the presence of chlamydia along with gonorrhea, providing a comprehensive approach to the patient's care. This dual therapy is particularly important given the rising incidence of chlamydia and the potential for these two infections to occur simultaneously in patients. Effective management involves treating both infections to prevent complications such as pelvic inflammatory disease, infertility, and the risk of transmission to sexual partners. This collaborative approach offers a responsible strategy in the face of prevalent sexually transmitted infections.

The patient with gonorrhea is receiving both ceftriaxone and doxycycline primarily because many cases of gonorrhea are co-infected with chlamydia. Chlamydia is another sexually transmitted infection that is often asymptomatic but can have serious complications if left untreated. By administering both antibiotics, the treatment addresses the presence of chlamydia along with gonorrhea, providing a comprehensive approach to the patient's care.

This dual therapy is particularly important given the rising incidence of chlamydia and the potential for these two infections to occur simultaneously in patients. Effective management involves treating both infections to prevent complications such as pelvic inflammatory disease, infertility, and the risk of transmission to sexual partners. This collaborative approach offers a responsible strategy in the face of prevalent sexually transmitted infections.